You are here

Clinical Trials: Stroke and Related

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, July 28, 2020 - 12:00
Condition:   Ischemic Stroke
Intervention:   Other: Autologous transplant
Sponsor:   Centre Hospitalier Universitaire Vaudois
Not yet recruiting
Posted: Wednesday, June 17, 2020 - 12:00
Conditions:   Stroke;   Hemiparesis;Poststroke/CVA (Cerebrovascular Accident)
Intervention:   Device: MyHand Device
Sponsors:   Columbia University;   National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
Posted: Wednesday, June 17, 2020 - 12:00
Condition:   Acute Stroke
Intervention:   Biological: UMSC01
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Posted: Friday, February 21, 2020 - 12:00
Conditions:   Ischemic Stroke;   Adipose Tissue-derived Stem Cell;   Functional Status
Interventions:   Other: Alogenic adipose tissue-derived stem cells;   Drug: Placebo solution
Sponsor:   Instituto de Investigación Hospital Universitario La Paz
Not yet recruiting
Posted: Thursday, February 20, 2020 - 12:00
Conditions:   Ischemic Stroke;   Hemorrhagic Stroke
Interventions:   Device: BCI-FES dorsiflexion therapy;   Behavioral: Physiotherapy one hour;   Behavioral: Physiotherapy two hours
Sponsor:   University of California, Irvine
Posted: Friday, February 7, 2020 - 12:00
Condition:   Hypoxia-Ischemia, Brain
Intervention:   Biological: CL2020 cells
Sponsors:   Nagoya University;   Life Science Institute, Inc.
Not yet recruiting
Posted: Monday, January 13, 2020 - 12:00
Condition:   Intraventricular Hemorrhage
Intervention:   Other: Human breast milk
Sponsors:   The Hospital for Sick Children;   MOUNT SINAI HOSPITAL
Not yet recruiting
Posted: Friday, October 11, 2019 - 12:00
Conditions:   Stroke;   Hemiparesis
Intervention:   Device: IpsiHand Treatment
Sponsors:   Columbia University;   Neurolutions, Inc.
Not yet recruiting
Posted: Friday, September 20, 2019 - 12:00
Condition:   Acute Ischemic Stroke
Intervention:   Biological: UMC119-06
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting
Posted: Wednesday, September 18, 2019 - 12:00
Conditions:   Infarction, Middle Cerebral Artery;   Infarction, Anterior Cerebral Artery;   Cerebral Infarction;   Stroke, Ischemic;   Acute Stroke
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Biological: Placebo;   Other: standardized treatment
Sponsor:   Shanghai East Hospital